VICTORY CAPITAL MANAGEMENT INC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 141 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2021. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
VICTORY CAPITAL MANAGEMENT INC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$11,407
-20.1%
11,640
+13.4%
0.00%
Q2 2023$14,273
-96.1%
10,268
-41.0%
0.00%
Q2 2021$368,000
-27.4%
17,390
-3.8%
0.00%
-100.0%
Q1 2021$507,000
+3.3%
18,079
-4.3%
0.00%0.0%
Q4 2020$491,000
-33.4%
18,895
-4.7%
0.00%0.0%
Q3 2020$737,000
-47.0%
19,824
-26.9%
0.00%
-50.0%
Q2 2020$1,391,000
+63.6%
27,114
+0.5%
0.00%
+100.0%
Q1 2020$850,000
-4.4%
26,976
+80.9%
0.00%0.0%
Q4 2019$889,000
+70.6%
14,909
+5.0%
0.00%0.0%
Q3 2019$521,000
+3907.7%
14,202
+5102.2%
0.00%
Q2 2019$13,000
+18.2%
2730.0%0.00%
Q1 2019$11,000
-15.4%
2730.0%0.00%
Q4 2018$13,000
-7.1%
273
-16.0%
0.00%
Q3 2018$14,000
+27.3%
325
+15.2%
0.00%
Q2 2018$11,000
-45.0%
2820.0%0.00%
Q1 2018$20,000
+5.3%
2820.0%0.00%
Q4 2017$19,000
+35.7%
2820.0%0.00%
Q3 2017$14,000
+7.7%
2820.0%0.00%
Q2 2017$13,000
+30.0%
282
+1.8%
0.00%
Q1 2017$10,000
+233.3%
2770.0%0.00%
Q4 2016$3,000
-25.0%
277
+6.5%
0.00%
Q3 2016$4,000
+100.0%
260
+7.4%
0.00%
Q2 2016$2,000
-50.0%
242
+2.1%
0.00%
Q1 2016$4,000
-20.0%
237
+8.2%
0.00%
Q4 2015$5,0000.0%219
+5.8%
0.00%
Q3 2015$5,000
-66.7%
207
+10.7%
0.00%
Q2 2015$15,0001870.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q3 2021
NameSharesValueWeighting ↓
Meditor Group Ltd 2,818,835$59,618,00021.09%
Bellevue Group AG 4,519,164$95,580,0000.93%
PLATINUM INVESTMENT MANAGEMENT LTD 1,713,176$36,234,0000.84%
Rhenman & Partners Asset Management AB 572,267$12,103,0000.82%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 64,434$1,363,0000.45%
Boxer Capital, LLC 500,000$10,575,0000.37%
EMC Capital Management 27,566$583,0000.33%
WASATCH ADVISORS LP 3,766,935$79,671,0000.32%
Avidity Partners Management LP 400,000$8,460,0000.23%
Cinctive Capital Management LP 186,170$3,937,0000.18%
View complete list of ESPERION THERAPEUTICS INC NE shareholders